Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/143063
Title: Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases
Author: Álvarez Palomo, Ana Belén
Barrot i Feixat, Carme
Sarret, Helena
Requena Osete, Jordi
Pau, Montserrat
Vidal Taboada, José Manuel
Oliva Virgili, Rafael
Ballesca, Josep-Lluis
Edel, Michael John
Mezquita Pla, Jovita
Keywords: Fecunditat humana
Espermatogènesi
Human fertility
Spermatogenesis
Issue Date: 8-Oct-2019
Publisher: Impact Journals
Abstract: The vascular endothelial growth factor receptor 1 (VEGFR-1) family of receptors is preferentially expressed in endothelial cells, with the full-length and mostly the soluble (sVEGFR-1) isoforms being the most expressed ones. Surprisingly, cancer cells (MDA-MB-231) express, instead, alternative intracellular VEGFR-1 variants. We wondered if these variants, that are no longer dependent on ligands for activation, were expressed in a physiological context, specifically in spermatogenic cells, and whether their expression was maintained in spermatozoa and required for human fertility. By interrogating a human library of mature testis cDNA, we characterized two new truncated intracellular variants different from the ones previously described in cancer cells. The new isoforms were transcribed from alternative transcription start sites (aTSS) located respectively in intron-19 (i19VEGFR-1) and intron-28 (i28VEGFR-1) of the VEGFR-1 gene (GenBank accession numbers JF509744 and JF509745) and expressed in mature testis and spermatozoa. In this paper, we describe the characterization of these isoforms by RT-PCR, northern blot, and western blot, their preferential expression in human mature testis and spermatozoa, and the elements that punctuate their proximal promoters and suggest cues for their expression in spermatogenic cells. Mechanistically, we show that i19VEGFR-1 has a strong ability to phosphorylate and activate SRC proto-oncogene non-receptor tyrosine kinases and a significant bias toward a decrease in expression in patients considered infertile by WHO criteria.
Note: Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.27232
It is part of: Oncotarget, 2019, vol. 10, num. 56, p. 5871-5887
URI: http://hdl.handle.net/2445/143063
Related resource: https://doi.org/10.18632/oncotarget.27232
ISSN: 1949-2553
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
692258.pdf4.07 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons